Omeprazole/Sodium Bicarbonate

奥美拉唑/碳酸氢钠

Report date: 2026/05/26 20:00:28

Base Information

Drug NameOmeprazole/Sodium Bicarbonate
Drug Alias NameSodium Bicarbonate and Omeprazole碳酸氢钠/奥美拉唑omeprazole and sodium bicarbonateSodium Bicarbonate/OmeprazoleZegerid +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsHeartburnStomach UlcerDuodenal Ulcer +[9] 
Global Approved IndicationsStomach UlcerDuodenal UlcerEsophagitis +[4] 
Approved Indications in ChinaStomach UlcerDuodenal UlcerEsophagitis +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date2004/06/15
Country/TerritoryUnited StatesMainland China
CombinationsYes OmeprazoleSodium Bicarbonate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSantarus Inc
China Registration ClassN/A

Develop Information

Active CompaniesBayer Healthcare Pharmaceuticals LlcAzurity Pharmaceuticals IncShandong Changli Pharmaceutical Co Ltd +[6] 
Inactive CompaniesHainan Jintian Pharmacy Co LtdSantarus IncSalix Pharmaceuticals +[16] 
Active IndicationsHeartburnStomach UlcerDuodenal Ulcer +[8] 
Inactive IndicationsPeptic Ulcer Hemorrhage

Other Information

ATC CodeA02BC
Related LinksN/A